Sex Differences in Cardiovascular Outcomes in Patients With Kidney Failure

Silvi Shah1, Annette L Christianson2, Karthikeyan Meganathan2

  • 1Division of Nephrology and Hypertension, Department of Internal Medicine University of Cincinnati Cincinnati OH USA.

Insights

Women undergoing dialysis face higher risks of heart failure and stroke but have lower mortality rates from cardiovascular causes and all-cause death compared to men. This highlights sex-based differences in cardiovascular outcomes for kidney failure patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology
  • Sex-based medicine

Background:

  • Cardiovascular disease (CVD) is the primary cause of death in patients with kidney failure.
  • These patients exhibit a 10-20 fold increased risk of cardiovascular events compared to the general population.

Purpose of the Study:

  • To investigate sex-based differences in cardiovascular event risk, cardiovascular death, and all-cause mortality among patients initiating dialysis.
  • To analyze the association between sex and specific cardiovascular outcomes including acute coronary syndrome, heart failure, and stroke.

Main Methods:

  • Evaluation of 508,822 patients initiating dialysis between 2005 and 2014 using the United States Renal Data System (USRDS) with linked Medicare claims.
  • Determination of hospitalization rates for cardiovascular events (acute coronary syndrome, heart failure, stroke).
  • Utilized adjusted time-to-event models to examine the association of sex with outcomes.

Main Results:

  • Women comprised 44.7% of the study cohort (mean age 70±12 years).
  • The overall cardiovascular event rate was 232 per 1000 person-years, higher in women (248) than men (219).
  • Women demonstrated a 14% higher risk of cardiovascular events (HR 1.14), 16% higher risk of heart failure (HR 1.16), and 31% higher risk of stroke (HR 1.31), but no difference in acute coronary syndrome risk (HR 1.01).
  • Conversely, women had a lower risk of cardiovascular death (HR 0.89) and all-cause death (HR 0.96) compared to men.

Conclusions:

  • Among dialysis patients, women experience a greater risk of heart failure and stroke than men.
  • Despite higher event rates, women exhibit a lower adjusted risk for both cardiovascular mortality and all-cause mortality.
  • Findings underscore significant sex-based disparities in cardiovascular outcomes and mortality within the end-stage renal disease population.
Abstract

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
322
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K